Stay Up To Date

Breaking Convention & Psychedelics News

GET THE LATEST

As the psychedelic renaissance gathers pace, increasing numbers of relevant news articles are being generated.  This is a critical part of our collective work to raise the importance of psychedelics across the world, in all disciplines and in a calm, neutrally-presented, evidence-based manner, particularly where it can assist with harm reduction.

Breaking Convention aims to reproduce as much of this news here in one convenient space, but we are near the start of this work.

Do get in touch if you know of articles recently published about either Breaking Convention or psychedelics in general and we'll take a look.

NEWS FROM THE PSYCHEDELIC SPHERE

    2019-06-07: Leafly.  Does Endocannabinoid Deficiency Play a Role in These Common Illnesses?
    2019-05-08: Forbes.  Denver Voters Approve Measure To Decriminalize Psychedelic Mushrooms
    2019-05-07: Psychopharmacology.  MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
    2019-04-25: Business Insider.  Tim Ferriss just helped launch the world's first research center dedicated to turning psychedelics into medicines
    2019-04-16: Psychedelic Times.  "I Think I Can Leave Afghanistan in the Past": Interview with a Military Psychologist about MDMA Therapy for PTSD
    2019-04-03: Psychedelic Times.  Why Is the Cannabis Industry Struggling to Build Social Equity in the City of Angels? An Interview with Kristen Lovell of the Social Impact Center, Los Angeles
    2019-03-30: Psychedelic Times.  FDA Approves Ketamine-Derived Treatment for Depression, But How Are People Really Using It? A Conversation with Kellye Greene of New York DanceSafe
    2019-03-06: Vox.  A ketamine-like drug is the first new antidepressant to get FDA approval in years
    2019-02-07: Filter.  Sure, Cannabis Is a “Gateway Drug”—Leading Toward Less Use of Other Drugs
    2018-10-25: New Atlas.  Psychedelic psilocybin therapy for depression granted Breakthrough Therapy status by FDA
    2018-10-18: BBC.  Canada becomes second country to legalise recreational cannabis
    2018-10-10: MSN.  The Legalization Issue: From medpot to the next frontier – psychedelics as medicine
    2018-10-03: Now Toronto.  A Peter Thiel-backed startup has raised $25 million to unleash a 'virgin market of for-profit psychedelic research'
    2018-08-20: MAPS.  Reduction in social anxiety after MDMA-assisted psychotherapywith autistic adults: a randomized, double-blind, placebo-controlledpilot study
    2017-08-17: MAPS.  FDA Grants Breakthrough Therapy Designation for MDMA-Assisted Psychotherapy for PTSD, Agrees on Special Protocol Assessment for Phase 3 Trials
    2017-07-05: Vice.  [Deutsch]  Dieser Mann hat in drei Jahren 600 mal DMT geraucht
    2017-07-03: Warp.  [Espanõl]  Comenzarán a usar el MDMA en Inglaterra para tratar el alcoholismo
    2017-07-03: Franceinfo.  [Français]  La MDMA pour soigner l'alcoolisme : attention de ne pas jouer « aux apprentis-sorciers »
    2017-07-02: The Sun.  E'S ARE GOOD Ecstasy being tested as part of revolutionary treatment to help alcoholics beat their addiction